|
|
|
|
|
|
|
|
|
|
"....The PROSE database was developed by 20 centers in the United States and Europe who identified and prospectively followed women with a deleterious BRCA1 or BRCA2 mutation. For the study, the investigators focused on those who at ascertainment had at least one ovary, no prior breast or ovarian cancer, no prior bilateral mastectomy, and at least 6 months of follow-up. ...."
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.